NJH-2-056

• CAT Number: I043627
• CAS Number: 2858812-69-6
• Molecular Formula: C41H40F2N6O8
• Molecular Weight: 782.79
• Purity: ≥95%
• Synonyms: 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]-N-[3-[3-[5-(2-oxo-4-prop-2-enoylpiperazin-1-yl)furan-2-yl]propanoylamino]propyl]benzamide
• InChI: InChI=1S/C41H40F2N6O8/c1-3-34(51)48-20-21-49(35(52)24-48)36-15-11-29(55-36)10-14-33(50)44-18-5-19-45-38(53)27-7-4-6-26(22-27)37-25(2)8-13-32(46-37)47-39(54)40(16-17-40)28-9-12-30-31(23-28)57-41(42,43)56-30/h3-4,6-9,11-13,15,22-23H,1,5,10,14,16-21,24H2,2H3,(H,44,50)(H,45,53)(H,46,47,54)
• InChIKey: SXPTYNZPHCBSCJ-UHFFFAOYSA-N
• SMILES: CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)NCCCNC(=O)CCC6=CC=C(O6)N7CCN(CC7=O)C(=O)C=C

NJH-2-056（Cat No.:I043627）is a selective peptide inhibitor designed to target specific enzymes involved in cellular signaling pathways. With high specificity and potency, it has shown potential in modulating protein interactions that contribute to various disease processes, including cancer, metabolic disorders, and neurodegenerative conditions. Its mechanism of action includes blocking critical enzyme activities that drive disease progression, offering a promising therapeutic strategy. NJH-2-056 is undergoing preclinical evaluations to determine its efficacy, safety profile, and potential for clinical application in treating complex diseases.